These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: A non-radioactive method for angiotensin II receptor binding studies using the rat liver.
    Author: Akhavan MM, Ebrahimi SA, Mahmoudian M.
    Journal: J Pharmacol Toxicol Methods; 2006; 53(3):206-14. PubMed ID: 16165374.
    Abstract:
    INTRODUCTION: A new non-radioactive method based on competitive ELISA has been developed for binding studies on angiotensin II (Ang II) receptors. METHOD: Rat liver membrane was used as the source of angiotensin receptors and FITC-angiotensin II (FITC-Ang II) was used as the labeled ligand with an affinity similar to unlabeled Ang II. The effects of different concentrations of Ang II, losartan, CGP-42112A and saralasin were studied on FITC-Ang II binding. RESULTS: The Ki values for Ang II, losartan and CGP-42112A were calculated as 0.52+/-0.22 nM, 6+/-3 nM and 0.15+/-0.07 nM, respectively. Saralasin inhibited the binding of labeled ligand biphasically, revealing two different populations of Ang receptor with different affinities for saralasin. About 74% of the binding sites were more sensitive to saralasin with a Ki value of 0.32+/-0.04 nM while saralasin showed a Ki value of 2.7+/-0.8 nM for the remaining binding sites. DISCUSSION: The competitive ELISA method developed in this work yields Ki values for angiotensin antagonists similar to those obtained by others using radiolabeled ligands. The simplicity of this method makes it a suitable alternative to radioligand studies for routine analysis of interaction of drugs with angiotensin receptors.
    [Abstract] [Full Text] [Related] [New Search]